[Form 4] AMERISAFE, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Anastasios Omiridis, EVP-CFO of Amerisafe, Inc. (AMSF), reported insider transactions dated 08/29/2025. The filing shows an acquisition of 4,565 restricted stock units (RSUs) that convert one-for-one into common stock, and a separate reported disposition of 1,797 common shares sold at $46.18. After these transactions the filing reports 18,922 shares beneficially owned by the reporting person. The RSUs originated from a Sept 1, 2022 grant of 22,826 RSUs that vest in four annual installments of 35%, 15%, 20%, and 30% beginning on Sept 1, 2023. The form is a standard Section 16 filing documenting these changes in ownership.

Positive

• Received 4,565 RSUs that convert one-for-one into common stock, increasing equity stake
• Filing discloses original grant and vesting schedule (22,826 RSUs granted 9/1/2022 with clear vesting percentages)

Negative

• Disposition of 1,797 shares at $46.18, reducing immediate shareholdings
• Total beneficial ownership after transactions is 18,922 shares, which may be lower than potential fully vested amounts

Insights

Financial Analyst

TL;DR: Insider converted RSUs into shares while selling a smaller block, leaving total beneficial ownership at 18,922 shares.

The filing shows a routine mix of equity vesting and a small open-market disposition. The reporting person received 4,565 RSUs that convert one-for-one to common stock, increasing potential equity exposure. Concurrently, 1,797 shares were sold at $46.18, a modest reduction relative to total reported holdings. These transactions reflect scheduled vesting from the 2022 grant rather than an extraordinary event. For valuation impact, the sale price provides one recent data point for realized insider proceeds but does not on its own indicate a material change to company ownership or control.

Corporate Governance Expert

TL;DR: Disclosure aligns with Section 16 requirements and documents scheduled vesting plus a small sale.

The Form 4 is complete in documenting both the vesting-related acquisition of RSUs and a contemporaneous disposal. The filing includes the original grant size and vesting schedule, which supports transparency about the timing and nature of the acquired securities. There is no indication of unusual trading patterns or Rule 10b5-1 plan notation on the face of the form; the transactions appear to be routine compensation vesting and a partial sale. This is a standard governance disclosure with no apparent compliance issues in the text provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Omiridis Anastasios

(Last) (First) (Middle)

2301 HIGHWAY 190 WEST

(Street)

DERIDDER LA 70634

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AMERISAFE INC [ AMSF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP-CFO

3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	08/29/2025		M		4,565	A	(1)	6,818	D
Common stock	08/29/2025		F		1,797	D	$46.18	5,021	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	08/29/2025		M			4,565	(2)	(2)	Common Stock	4,565	$0	18,922	D

Explanation of Responses:

1. Restricted stock units convert into common stock on a one-for-one basis.

2. On September 1, 2022, the reporting person was granted 22,826 restricted stock units, vesting in four annual installments of 35%, 15%, 20%, and 30% beginning on September 1, 2023, the first anniversary of the grant date.

	/s/ Anastasios Omiridis	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did AMFS insider Anastasios Omiridis report on 08/29/2025?

The filing reports an acquisition of 4,565 RSUs (one-for-one conversion to common stock) and a sale of 1,797 common shares at $46.18.

How many shares does Anastasios Omiridis beneficially own after these transactions (AMSF)?

The Form 4 states the reporting person beneficially owns 18,922 shares following the reported transactions.

What is the origin and vesting schedule of the RSUs reported by the AMFS insider?

The RSUs come from a grant on September 1, 2022 of 22,826 RSUs, vesting in four annual installments of 35%, 15%, 20%, and 30% beginning on Sept 1, 2023.

Was the sale executed at a disclosed price for AMFS insider shares?

Yes, the Form 4 discloses a disposal of 1,797 shares at $46.18.

Does the Form 4 indicate compliance with Section 16 disclosure requirements for AMSF?

The filing is a standard Section 16 Form 4 that documents the transactions and includes signature and date, indicating required disclosure was made.